DNTH icon

Dianthus Therapeutics
DNTH

Overview Fund Activity

90 hedge funds and large institutions have $418M invested in Dianthus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 14 closing their positions.

Holders
90
Holders Change
-2
Holders Change %
-2.17%
% of All Funds
1.58%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
26
Reduced
29
Closed
14
Calls
$739K
Puts
$182K
Net Calls
+$557K
Net Calls Change
+$675K

Top Buyers

1
O
1
OrbiMed
New York
$11.2M
2
Citadel Advisors
2
Citadel Advisors
Florida
$9.18M
3
CAM
3
Cormorant Asset Management
Massachusetts
$7.1M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$7.96M
5
EC
5
EcoR1 Capital
California
$6.59M

Top Sellers

1
EAM
1
Eventide Asset Management
Massachusetts
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$10K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
TCM
4
Tekla Capital Management
Massachusetts
$0
5
PM
5
Prosight Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
101
Simplex Trading
Illinois
– -$10K -87 Closed
Osaic Holdings
102
Osaic Holdings
Arizona
– -$8K -63 Closed
PHK
103
Point72 Hong Kong
Hong Kong
– -$6K -46 Closed
1 2 3 4
5